Achieve Life Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Achieve Life Sciences generated cash of -$24,479,000, which is more than the previous year. Cash used in financing activities reached the amount of $15,278,000 last year. Net change in cash is therefore -$9,225,000.
Cash Flow
| 2014 | -17.30M | 5.36M | 25.24M |
|---|---|---|---|
| 2015 | -9.10M | -2.07M | 17.59M |
| 2016 | -29.68M | 10.60M | -2K |
| 2017 | -9.10M | 12.64M | 2.00M |
| 2018 | -10.62M | -5.12M | 19.75M |
| 2019 | -15.21M | 5.03M | 17.32M |
| 2020 | -13.47M | -17K | 32.68M |
| 2021 | -29.44M | -17K | 36.61M |
| 2022 | -37.54M | 0 | 19.29M |
| 2023 | -24.47M | -21K | 15.27M |
ACHV Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 24.77M | 43.07M | 35.90M | 16.71M | 9.56M | 5.55M | 15K | 34.31M | 27.89M | 14.59M |
Operating activities | ||||||||||
Net income | -29.81M | -42.35M | -33.15M | -14.73M | -16.39M | -12.68M | -10.58M | -20.12M | -16.80M | -26.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 228K | 236K | 250K | 255K | 254K | 282K | 282K | 188K | 244K | 223K |
Stock-based compensation expense | 3.43M | 3.27M | 2.18M | 1.28M | 1.20M | 0 | 348K | 1.64M | 2.32M | 3.86M |
| Deferred income tax benefit | 3.43M | 3.27M | 2.18M | 1.28M | 1.20M | 0 | 348K | 1.64M | 2.32M | 3.86M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 48K | -153K | 0 | -1K | 2K | -9K | -464K | 5.66M | 2.98M |
Inventories | 0 | -48K | 153K | 0 | 1K | 285K | -3.65M | -4.91M | -4.86M | 8.97M |
Accounts payable | -1.04M | 819K | 509K | -527K | 715K | -69K | 118K | 778K | 1.27M | -67K |
Cash generated by operating activities | -24.47M | -37.54M | -29.44M | -13.47M | -15.21M | -10.62M | -9.10M | -29.68M | -9.10M | -17.30M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -25K | -5.53M | 0 | -36.50M | -24.36M | -19.44M |
Investments In Property Plant And Equipment | -21K | 0 | -17K | -17K | -53K | -46K | 0 | -46K | -371K | -82K |
Acquisitions Net | 0 | 0 | 0 | 0 | -5.08K | 10K | 12.64M | 0 | -3K | 0 |
Cash generated by investing activities | -21K | 0 | -17K | -17K | 5.03M | -5.12M | 12.64M | 10.60M | -2.07M | 5.36M |
Financing activities | ||||||||||
Common Stock Issued | 15.30M | 19.21M | 21.34M | 29.49M | 13.12M | 18.43M | 1.94M | 0 | 17.62M | 25.24M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -30K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -14.92M | 0 | 0 | 0 | 64K | 0 | 0 | 0 |
Cash used in financing activities | 15.27M | 19.29M | 36.61M | 32.68M | 17.32M | 19.75M | 2.00M | -2K | 17.59M | 25.24M |
Net Change In Cash | -9.22M | -18.25M | 7.16M | 19.18M | 7.14M | 4.00M | 5.54M | -19.07M | 6.41M | 13.30M |
Cash at end of period | 15.54M | 24.82M | 43.07M | 35.90M | 16.71M | 9.56M | 5.55M | 15.23M | 34.31M | 27.89M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |